Mariella Valenzise

Prof. Dr. Mariella Valenzise

department of Human Pathology of adulthood and childhood, University of Messina, Messina, Sicilia, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2015 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
TATommaso Aversa
Tommaso Aversa
FLFortunato Lombardo
Fortunato Lombardo
Mariella ValenziseMariella Valenzise
Mariella Valenzise
MMMaria Francesca Messina
Maria Francesca Messina
CSConcetta Sferlazzas
Concetta Sferlazzas
Malgorzata WasniewskaMalgorzata Wasniewska
Malgorzata Wasniewska
Aim of this commentary is to summarize the salient literature news on the relationships between autoimmune thyroid diseases (ATDs) and either Down syndrome (DS) or Turner syndrome (TS). According to literature reports both Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are more frequent in children with DS or TS than in those without these chromosomopathies. An up-regulation of proinflammatory cytokines might be responsible for the enhanced susceptibility of TS children to ATDs, whereas a dysregulation of immune system may favor the development of ATDs in DS. In TS children biochemical presentation of HT is less severe than in peer controls. In both DS and TS GD picture at the time of diagnosis is not significantly different than in the pediatric general population. The evolution over time of GD in DS and TS does not differ from that observed in the pediatric general population, whereas the evolution of HT in both TS and DS is more severe than in girls without these chromosomopathies. Conclusions: The association with TS or DS is able to affect both epidemiology and course of ATDs by conditioning: a) an increased susceptibility to these disorders; b) a less severe biochemical presentation and a more severe evolutive pattern of HT in TS girls; c) a more severe biochemical presentation and evolution of HT in DS patients.

18 October 2021 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Mariella ValenziseMariella Valenzise
Mariella Valenzise
FDFederica D'Amico
Federica D'Amico
UCU. Cucinotta
U. Cucinotta
CLC. Lugarà
C. Lugarà
GZG. Zirilli
G. Zirilli
GPG. B. Pajno
G. B. Pajno
Background: The social consequences of COVID-19 pandemic are universally known. In particular, the pediatric population is dealing with a radical lifestyle change. For some risk categories, such as overweight or obese children, the impact of home confinement has been greater than for others. The increased sedentary life, the wrong diet and social distancing have stopped the chance of losing weight. The aims of this study were to analyse the impact of COVID-19 lockdown on the behavior changes in a obese pediatric population and to explore the correlation between the new lifestyle and the level of parental instruction. Methods: Data show features of 40 obese and overweight pediatric patients of our Clinic in Messina (Italy). We evaluated weight, height, BMI and other biochemical parameters: total cholesterol, HDL, LDL, triglyceride, transaminases, glycemia and insulinemia. After the lockdown, we contacted all patients in order to get some information about diet, physical activity and sedentary lifestyle changes in correlation to the level of their parents’ instruction. Additionally, we also evaluated 20 children twice from a clinical and laboratory perspective. Results: The study showed an increase of daily meals during COVID-19 lockdown (3.2 ± 0.4 vs 5 ± 1, P < 0.001). In particular, children whose parents have primary school diploma ate a greater significant number of meals during the lockdown, compared to those who have parents with secondary school diploma (P = 0.0019). In addition, the 95% of patients did low physical activity during the lockdown and the 97.5% spent more time in sedentary activity. Even if BMI’s values don’t show significant differences, they have increased after the lockdown. We didn’t find any correlation between biochemical parameters before and after the lockdown. Conclusion: The lockdown has had bad consequences on good style of life’s maintenance in overweight and obese children. The absence of a significant correlation between the worsening of biochemical parameters and the lockdown doesn’t allow to exclude any long-term consequences. It’s safe to assume that, if the hours spent in sedentary activity and the number of meals don’t diminish, there will probably repercussion on the biochemical parameters.

31 January 2014 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
PDF file
Mariella ValenziseMariella Valenzise
Mariella Valenzise
TATommaso Aversa
Tommaso Aversa
ACAndrea Corrias
Andrea Corrias
LMLaura Mazzanti
Laura Mazzanti
MCMarco Cappa
Marco Cappa
Malgorzata WasniewskaMalgorzata Wasniewska
Malgorzata Wasniewska
Background: Epidemiological studies on the association between Turner syndrome (TS) and Graves' disease (GD) are sparse and no studies are available on the clinical course of GD in TS. Objectives: To retrospectively investigate the GD prevalence in children and young adults with TS and to compare the GD course in patients with or without TS who were followed up for 4.1 ± 0.6 and 4.5 ± 3.7 years, respectively. Design: The prevalence of GD in 408 TS patients was evaluated; presentation and evolution of GD under therapy were evaluated both in 7 patients with TS (group A) and in 89 patients without TS (group B). Results: (a) The prevalence of GD in TS patients was 1.7%; (b) GD in TS was not associated with a specific karyotype; (c) with respect to group B patients, those of group A exhibited at presentation more advanced age, a lower fT4 level and more frequent association with other autoimmune diseases, and (d) the clinical course under methimazole therapy was not different in the two groups. Conclusions: The prevalence of GD in children and young adults with TS is 1.7% and in TS patients, GD presents later and its clinical course is not different than in those without TS.

17 February 2018 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
RGR. Gallizzi
R. Gallizzi
GCGiuseppe Crisafulli
Giuseppe Crisafulli
TATommaso Aversa
Tommaso Aversa
GSGiuseppina SALZANO
Giuseppina SALZANO
FLF. De Luca
F. De Luca
GZG. Zirilli
G. Zirilli
Aim of this commentary is to report current knowledges on the main clinical and metabolic abnormalities which might be observed in children with longstanding and untreated subclinical hypothyroidism (SH) and to comment the most recent views about natural evolution of thyroid function in the cases with either idiopathic or Hashimoto’s thyroiditis-related SH. On the basis of these preliminary remarks, the essential guidelines for an appropriate and tailored management of SH children are also proposed.

21 March 2018 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
TATommaso Aversa
Tommaso Aversa
GCGiuseppe Crisafulli
Giuseppe Crisafulli
GZGiuseppina Zirilli
Giuseppina Zirilli
FLFilippo De Luca
Filippo De Luca
RGRomina Gallizzi
Romina Gallizzi
Mariella ValenziseMariella Valenzise
Mariella Valenzise
Aim of this commentary is to report the main peculiarities that have been found to characterize the phenotypic expression of autoimmune thyroid diseases (AITDs) in children with Down’s syndrome (DS). According to recent reports, DS children are, per se, more exposed to the risk of both Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), irrespective of other concomitant risk factors, such as female gender and family antecedents for AITDs. In the context of extra-thyroidal autoimmune disorders, the ones that preferentially aggregate with AITDs in DS children are alopecia areata and vitiligo. Another peculiar aspect, in DS children, is that HT presents with a more severe biochemical picture, which furtherly deteriorates over time. By contrast, GD does not demonstrate a more severe clinical and biochemical picture with respect to that generally observed in patients without DS. Finally, DS children might be at higher risk of progressing from HT toward GD over time.

11 November 2015 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
TATommaso Aversa
Tommaso Aversa
Mariella ValenziseMariella Valenzise
Mariella Valenzise
MSMariacarolina Salerno
Mariacarolina Salerno
ACAndrea Corrias
Andrea Corrias
Lorenzo IughettiLorenzo Iughetti
Lorenzo Iughetti
Malgorzata WasniewskaMalgorzata Wasniewska
Malgorzata Wasniewska
It is known that Hashimoto’s thyroiditis (HT) may progress to Graves’ disease (GD) and that this phenomenon may be more frequent in the patients with Down syndrome (DS). To shed light on the relationships between Down syndrome (DS) and metamorphic thyroid autoimmunity. We reconstructed the conversion process from HT to GD in 12 DS children. All the data recorded at HT diagnosis and throughout the time interval from entry to GD presentation were retrospectively taken from patients’ files, as well as those recorded at GD diagnosis and during the subsequent evolution. From GD diagnosis all patients underwent methimazole treatment, at a dose that was adjusted on the basis of clinical findings and thyroid tests. Time interval between HT and GD was not different in the seven patients who received during that time a L-thyroxine (L-T4) treatment than in those who were not treated. After methimazole onset all patients exhibited a prolonged remission of hyperthyroidism. In 8/12 patients this treatment is still being continued 2–7 years after its initiation. The mean methimazole dosage needed to maintain euthyroidism in these eight patients was 0.12 ± 0.02 mg/kg/day. In the remaining four patients methimazole was withdrawn from 1.9 to 7 years after its initiation and no relapses were recorded 2.0–2.1 years after its withdrawal. These patients developed, 0.1–0.3 years after methimazole withdrawal, a picture of overt hypothyroidism and needed treatment with L-T4, that is now being continued. No patients needed non-pharmacological therapies. 1) DS children might be incline to manifest over time a phenotypic metamorphosis from HT to GD and to subsequently fluctuate from hyperthyroidism to hypothyroidism; 2) in DS GD may have a mild biochemical and clinical course.